DHR
Danaher Corporation
NYSE · Healthcare · Medical - Diagnostics & Research · US
$206.31
−2.24%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
23.3x
EV/EBITDA
23.4x
Market Cap
$145.03B
MomentumView details →
1D Return
−2.24%
YTD Return
−8.62%
RSI (14)
52.7
ValuationView details →
P/E (Fwd)
23.3x
EV/EBITDA
23.4x
Market Cap
$145.03B
RSI (14)
52.7
MomentumView details →
1D Return
−2.24%
YTD Return
−8.62%
SummaryUpdated Jun 1, 2026
Danaher Corporation (NYSE:DHR) is a diversified life sciences and diagnostics company founded in 1969 and headquartered in Washington, D.C. Originally established as Diversified Mortgage Investors, Inc., the company underwent a significant transformation and changed its name to Danaher Corporation in 1984. Over the decades, Danaher has evolved from a diversified industrial conglomerate into a focused life sciences powerhouse through strategic acquisitions and divestitures. The company went public in 1978 and has since built a portfolio of leading brands serving the biotechnology, life sciences research, and clinical diagnostics markets worldwide.
Similar companies
Latest newsMore news →
NANO Holdings announced that Jack Yamamori, with extensive M&A and management experience in the US, was appointed Vice Chairman in August 2026 to accelerate investment business growth.19d agoMasimo appointed Tim Benner as president, succeeding Katie Szyman who stepped down in June, following the company's acquisition by Danaher.25d ago